HCMV Glycoprotein B (gB) Protein, His Tag

Proteins and Peptides

貨號 Cat. No.
CMB-V52H3
規格 Size
500ug
品牌 Brand
ACROBiosystems
Species
HCMV
Conjugate
Unconjugated
Expression System
HEK293
Tag
His Tag

Description




Source : 


HCMV Glycoprotein B (gB), His Tag (CMB-V52H3) Val 23 - Lys 700, Arg 777 - Val 907 (Accession # P13201-1) with furin cleavage site mutated from 'RTKR' to 'TTQT', was produced in human 293 cells (HEK293) at ACROBiosystems.


 

Molecule : Glycoprotein B / gB


 

Synonyms : Glycoprotein B,gB,Envelope glycoprotein B


 

Format : Powder


 

Category : Viral Proteins


 

Accession : N/A


 

Storage : -20℃


 

Shipping condition : Powder,RT


 

Molecular Weight : 93.7 kDa


 

Characteristics :


This protein carries a polyhistidine tag at the C-terminus. The protein has a calculated MW of 93.7 kDa. The protein migrates as 116-130 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.


 

Endotoxin Level : Less than 1.0 EU per μg by the LAL method.


 

Buffer : PBS, pH7.4


 

Description :


Human cytomegalovirus is a species of the Cytomegalovirus genus of viruses, which in turn is a member of the viral family known as Herpesviridae or herpesviruses. It is typically abbreviated as HCMV or, commonly but more ambiguously, as CMV. CMV Virus Envelope Glycoportein B (CMV-GB) can be cleaved into glycoprotein GP55. Envelope glycoprotein that plays a role in host cell entry, cell to-cell virus transmission, and fusion of infected cells. CMV-GB may be involved in the initial attachment via binding to heparan sulfate together with the gM/gN complex that binds heparin with higher affinity. Furthermore, CMV-GB can interact with host integrin ITGB1, PDGFRA and EGFR that likely serve as postattachment entry receptors. Also, CMV-GB participates in the fusion of viral and cellular membranes leading to virus entry into the host cell. Membrane fusion is mediated by the fusion machinery composed at least of gB and the heterodimer gH/gL.


 

References :


(1) Wang X., et al., 2002, Nature 424:456-461.
(2) Feire A.L., et al., 2009, J. Virol. 84:10026-10037.
(3) Halary F., et al., 2001, Immunity 17:653-664.





詢價 / 洽詢此產品

同品牌其他產品

回到產品列表

▲ LINE
諮詢